Eye Health Should be addressed as a Population Management Problem, according to a report issued by the National Academies of Sciences, Engineering, and Medicine (NASEM).
NASEM declares eye health a public health imperative | OphthalmologyTimes
The diagnosis of cataract with it’s ensuing visual challenges has led to a progressive step wise improvement in technique, hospitalization (or lack thereof), a brief post operative recovery period and fewer intraoperative and post-operative complications during recovery.
Intracapsular surgery with aphakia and rehabilitation with contact lenses or aspherical high diopter spectacle lenses became obsolete, replaced by extra capsular manual cataract removal, followed by the development of ultrasound phacoemulsification of the crystalline lens. This technique allowed for the safer implantation of a pseudophacos in the anatomical space.
Further manual refinement included capsulorrhexix of the anterior capsule, allowing for a consistent placement of the artificial lens inside the vacant lens capsule.
Clinical experience and patient expectations motivated further refinement of pseudophacos design in materials, haptic design, and multi-focal design.
The addition of refractive surgical techniques using arcuate corneal incisions, astigmatic pseudophacos further evolved the cataract operation to one where over 80% of patients no longer needed any correction after surgery and could return to work in 24 hours, with some exceptions for laborers or very physically active patients.
The development of YAG laser allowed for a non invasive procedure for the common occurrence of ‘after-cataract:
FEMTO-SECOND LASER for cataract surgery has added another tool, further refining and automating much of the procedure, with the assistance of advanced imaging for precision, replication and repeatability of the procedure.
ALCON , known for it’s ophthalmic products and commitment to cataract removal has developed the “LenSx Laser” platform integrating a robotic system which consist of the microscope, coupling device, femto-second laser, integrated ocular coherence tomography (OCT) combined with a three dimensional imaging system which images the entire anterior segment down to the posterior capsule.
Once the image is obtained and the metrics are computed the resulting combination allows for corneal entrance incisions, arcuate astigmatic corneal incisions, anterior capsulotomoy, and nuclear quadrantic dissection without surgeon intervention.
The last steps, phacoemulsification and placement of the intra-ocular lens require the use of a phaco-emulsifier, a technique which has been used for about 30 years.
Modern state of the art cataract removal has been facilitated and has been highly effective in improving outcomes, and reducing the cost of this surgery (which is done over 2 million times/year in the United States.
Previously the cost including surgeon’s fees, three days of in patient hospitalization has been reduced from over 4500 per eye to a one hour surgery as an outpatient with a cost of under 1800 dollars to Medicare.
Ophthalmology has had this in place for 30 years !
Quote of the Day:
Quote of the Day:
When you come to a fork in the road...take it.
--Yogi Berra
Dr Thulasira Ravilla speaks about efficient methods of delivering surgical care and creating an environment of change process at a T.E.D. conference.
This is a timely subject given that in the United States an attempt is being made to reduce costs, and deliver more care by placing additional burdens upon the healthcare system, physicians, hospitals and other caregivers.
Necessity has a way of driving improvement and reducing costs, however we have chosen the easy path.
His talk outlines the deep understanding of what up-regulates health care costs which is totally ignored in the equation for the United States.
The US health system has exhibited inflation, and we are told its rate of inflation exceeds that for the overall economy. It is estimated that it represents over 16% of the economy.
Healthcare institutions, medical clinics, hospitals all must operate in a general economy and thus compete with not only other health providers for patients, and also for durable medical goods, utilities, operating space, personnel costs, taxes, training and education.
Dr Ravilla explains in the T.E.D. video how his organization, , has become not only efficient, but how they deal with the side of the equation not addressed in the United States, overhead.
Currently large medical institutions will ask for RFIs or offer competitive bidding to obtain volume discounts. Smaller entities will form or joking a buying group to scale their purchasing power.
What is not addressed is the control of escalating cost for producing items.
In health care (which in some ways is like the military) there is a constant obsolescence factor for technology, in diagnostic equipment, therapeutics, new facilities and R & D. This cost is significant not only to manufacturers but to medical business. Recently we are adding Electronic Medical Records and Health Information Exchange, purportedly to improve efficiency and deliver improved outcomes. This will be subsidized by an incentive program for the federal government for almost 20 billion dollars. The immediate effect is to stimulate adoption of EMR, necessary because most entities can little afford this jump in technological advance, at the same time as maintaining technical competence in medical equipment.
While a significant amount it appears to be inadequate to offset the adoption and long term support for EMR. The additional expense will fall upon each medical clinic and hospital. The incentive program is a dual edge sword, both incentive and penalty if users do not convert to EMR with certain basic meaningful uses spelled out by HHS. The incentive program ignores continuing maintenance cost and periodic software and/or hardware updates and replacement.
The net effect is to increase operating expense and fuel further health care inflation. The $ 20 billion stimulus attracts new industry to health care in a massive manner. Health care’s primary goal is patient health. All other businesses surrounding this goal are a cost of delivering services. Adding another layer of bureaucracy, or personnel adds to operating cost.
Also change itself creates expense. The adoption and transition form one paradigm to another interrupts business productivity, requires personnel training and capital investment.
Ophthalmology has been no stranger to disruptive technology and innovation that have altered the landscape for practitioners, hospitals, industry and the most important component….patients.
The quick view;
Retinal laser photocoagulation
Coaxial Operating Microscope
Conversion to extra capsular cataract removal
Phacoemulsification, small incision surgery
Viscoelastic
Development and refinement of intraocular lenses
Transition to Outpatient Surgery
Retina: Development and refinement of the BIO. Operating microscope with Image Inverter. Intraocular gas, silicone oil and intraocular pharmacology, including antibiotics, anti-vegf compounds, corticosteroids.
These developments were fueled by translational research, and each innovation fueled further improvements in diagnostic equipment and therapeutic options